Powered by

Ceapro underperforms 94% of the market March 03, 2017 17:00 EST

Mar 3, 2017 - News Bites Canadian Markets


Ceapro Inc. (TSXV:CZO), Canada's 16th largest Biotechnology company by market cap, has dropped 4.0c (2.5%) from its last trading session of March 02 to close at CAD1.58. Compared with the S&P/TSX 60 Index which rose 4.4 points (0.5%) in the day, the relative price change was -2.9%. The volume was 0.5 times the average daily trading volume of 249,161 shares. In the Canadian market of 1,933 stocks and 85 units traded today, the stock has a 8-week relative price st

Sign up for unrestricted access to 200+ subscription services.
Already have an account? Click here to login.

RelSci News & Alerts gets you:

  • 5 free articles a month from top subscription outlets like the Financial Times, New York Times, and Washington Post
  • Competitive business intelligence through daily data updates
  • Custom feeds on target high-value individuals, companies, industries, and topics delivered straight to your inbox